Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 12 Show results per page	View Search Criteria \| Help With Results

Last Modified: 9/26/2006 First Published: 7/1/2002


1.		Phase II Pilot Study of Etanidazole Derivative EF5 for the Measurement of Tumor Hypoxia in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Diagnostic				Closed				18 and over				NCI				DUMC-0041-M1RB00622 NCI-2310, NCT00041028, 2310

Last Modified: 11/14/2006 First Published: 11/1/2002


2.		Phase II Pilot Diagnostic Study of EF5 Uptake and Concentration of Oxygen-Related Metabolites in Patients With Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Diagnostic				Completed				18 and over				NCI				DUMC-3512-02-3 NCI-5929, NCT00049140, 5929

Last Modified: 10/23/2006 First Published: 11/24/2002


3.		Phase II Randomized Study of Hyperbaric Oxygen Treatments in Previously Treated Patients With Laryngeal or Adjacent Pharyngeal Malignancies Undergoing Laryngectomy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				18 and over				NCCAM, NCI				UPCC-17300 NCI-5909, UPCC-IRB-702641, 5909, NCT00026975

Last Modified: 7/19/2007 First Published: 3/24/2005


4.		Phase II Pilot Study of EF5 Binding for the Detection of Tumor Hypoxia in Patients Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Diagnostic, Treatment				Completed				18 and over				NCI				UPCC-03804 7034, NCI-7034, NCT00107445

Last Modified: 5/27/2005 First Published: 5/1/1998


5.		Phase I Study of the Etanidazole Derivative EF5 for the Detection of Hypoxia in Patients With Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Diagnostic, Treatment				Completed				18 and over				NCI				UPCC-7597 NCI-T97-0045, NCT00003282, T97-0045, UPCC-1663-0

Last Modified: 6/1/2002 First Published: 2/1/2000


6.		Phase I Study of the Etanidazole Derivative EF5 for the Detection of Hypoxia in Patients With Breast, Head and Neck, Prostate, or Cervical Carcinoma or High Grade Soft Tissue Sarcomas (Summary Last Modified 06/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Diagnostic				Closed				18 and over				NCI				CAN-OCI-T98-0048 NCI-T98-0048, NCT00004261, T98-0048

Last Modified: 1/30/2007 First Published: 4/23/2005


7.		Phase I Study of Positron Emission Tomography Using Fluorine F 18 EF5 for the Detection of Tumor Hypoxia in Patients With Newly Diagnosed Brain Tumors Undergoing Surgery or Biopsy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Diagnostic, Treatment				Completed				18 and over				NCI				UPCC-01304 NCI-5999, 5999, NCT00110032

Last Modified: 10/15/2007 First Published: 1/25/2007


8.		Study of Etanidazole Derivative EF5 for Detection of Tumor Hypoxia in Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Gliomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Treatment				Completed				18 and over				NCI				UPCC-1301 UPCC-IRB-702859, NCI-4950, 4950, NCT00430079

Last Modified: 10/15/2007 First Published: 1/1/2002


9.		Study of the Etanidazole Derivative EF5 for the Detection of Hypoxia and Vascularity in Patients With Intraperitoneal or Pleural Malignancies Treated With Photodynamic Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic				Completed				18 and over				NCI				UPCC-05901 NCI-4110, 4110, UPCC-IRB-702341, NCT00028782

Last Modified: 10/15/2007


10.		Study of EF5 for the Detection of Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma of the Trunk or Extremity or Squamous Cell Carcinoma of the Oral Cavity

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis				Completed				18 and over				NCI				UPCC-3300 UPCC-IRB-701019, NCI-3950, 3950

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute